3,683
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Fractures in the framework: limitations of classification systems in psychiatry


Fracturas en el armazón: limitaciones de los sistemas de clasificación en psiquiatría

Les limites des systèmes de classification en psychiatrie ou quand le cadre vole en éclats

, &

Abstract

This article examines the limitations of existing classification systems from the historical, cultural, political, and legal perspectives. It covers the evolution of classification systems with particular emphasis on the DSM and ICD systems. While pointing out the inherent Western bias in these systems, it highlights the potential of misuse of these systems to subserve other agendas. It raises concerns about the reliability, validity, comorbidity, and heterogeneity within diagnostic categories of contemporary classification systems. Finally, it postulates future directions in alternative methods of diagnosis and classification factoring in advances in artificial intelligence, machine learning, genetic testing, and brain imaging. In conclusion, it emphasizes the need to go beyond the limitations inherent in classifications systems to provide more relevant diagnoses and effective treatments.


Este artículo examina las limitaciones de los sistemas de clasificación existentes desde perspectivas históricas, culturales, políticas y legales. Aborda la evolución de los sistemas de clasificación con especial énfasis en los sistemas DSM y CIE. Aunque se señala el inherente sesgo occidental de estos sistemas, también se destaca el potencial del mal uso de estos sistemas para favorecer otros objetivos. Se plantean preocupaciones acerca de la confiabilidad, validez, comorbilidad y heterogeneidad dentro de las categorías diagnósticas de los sistemas de clasificación contemporáneos. Finalmente, se proponen direcciones futuras en cuanto a métodos alternativos de diagnóstico y factorización de la clasificación de acuerdo con avances en inteligencia artificial, aprendizaje automático, pruebas genéticas e imágenes cerebrales. En conclusión, se enfatiza la necesidad de ir más allá de las limitaciones inherentes a los sistemas de clasificación para proporcionar diagnósticos más relevantes y tratamientos efectivos.

Les limites des systèmes actuels de classification sont analysées ici à partir de points de vue historique, culturel, politique et légal. L’article trace leur évolution en mettant l’accent sur le DSM et la CIM. Outre leur parti-pris occidental, ces systèmes peuvent être utilisés à d’autres fins abusives. Voici qui soulève des interrogations quant à la fiabilité, la validité, la comorbidité et l’hétérogénéité des catégories diagnostiques des systèmes de classification actuels. D’autres méthodes de diagnostic et de classification pourraient voir le jour en tenant compte des progrès de l’intelligence artificielle, de l’apprentissage automatique, des tests génétiques et de l’imagerie cérébrale. Les auteurs concluent sur la nécessité de dépasser les limites des systèmes de classification afin de proposer des diagnostics plus pertinents et des traitements plus efficaces.

Introduction


Classification systems are integral to medical practice. They facilitate diagnosis and thereby impact treatment and prognosis. Further, they enable communication with patients as well as amongst clinicians, researchers, training institutions, judicial systems, and insurance companies. Citation1 In psychiatry, the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM-5) Citation2 and the International Classification of Disorders 11 (ICD-11) Citation3 are the main classification systems in current use. They have evolved over several years and, although not perfect, perform a significant role in psychiatric research and clinical practice. Citation4

Psychiatry is probably the only medical specialization to have twice endured a complete discarding of its knowledge, which suggests that the classification of psychiatric disorders is more complex than it seems.5,6 This review covers some of the limitations of classification systems in psychiatry, focusing on historical and current fissures in the systems.


Historical perspective


Between 1500 and 1000 BC, ancient Indian scriptures, specifically the Atharva-Veda, provided the earliest descriptions 
of modern psychiatric illness.7 Illnesses were classified based on an imbalance of three biological energies or doshas: vata, pita, and kapha.8 In the 2nd century AD, Galen postulated four categories of temperament: choleric, sanguine, melancholic, and phlegmatic. Excess in one of the temperament humours was linked to an associated pathology.4


Emil Kraepelin’s classification in Compendium and Theodor Meynert’s efforts to map mental illness on the brain were important contributions in the development of the current classification systems. Citation9,Citation10 However, these classifications often mistook isolated symptoms for illnesses, unduly increased the number of categories of disorders, and were primarily based on patient histories. The European nosological tradition which started in the 18 th century was primarily symptom-based. Citation5

Within the United States (US), there were four official diagnostic classification systems following World War II. In order to overcome this somewhat chaotic state, the American Psychiatric Association (APA) initiated the creation of a new nosology based on psychoanalytic theory. This effort was influenced by a military manual referred to as Technical Medical Bulletin number 203 of the United States Army, which was issued in 1945. This document, directed by psychoanalyst William Menninger, became the basis of DSM . Citation5,Citation11

DSM-I and DSM-II were developed for the purpose of gathering statistical information on the prevalence of mental disorders. When the first DSM was published in 1952, psychoanalytic theory dominated American psychiatry. Although an etiological framework was used to classify mental disorders, they were viewed as “reactions” to stressors implying their psychodynamic causality. The second edition attempted a more atheoretical position; however, the nomenclature was still psychodynamic, with replacement of the term “reaction” with the term “neurosis.” Citation12Citation14

In the mid-1970s, the lack of empirical research evidence led to the questioning of the legitimacy of psychiatric diagnosis. Thomas Szasz and the antipsychiatry movement considered mental illness a myth. Citation15

In 1970, the US-UK Diagnostic Project found that US clinicians used a broader, more inclusive concept of schizophrenia based on psychoanalytic theory, whereas the British clinicians used more stringent criteria in diagnosis. This led to overdiagnosis of schizophrenia within the US and subsequently greater hospital admissions, resulting in discrepancies in prevalence data amongst the two countries. Citation16,Citation17

In view of these criticisms, DSM-III , based on the Feighner criteria, took on an atheoretical approach. Citation18,Citation19 It provided a new hierarchical, multiaxial system for diagnosis utilizing exclusion criteria and introduced the formal operationalization of psychiatric diagnosis with established reliability. Citation20 The new system stimulated empirical research, which showed flaws in the existing diagnostic criteria. It was seen to have low validity, taking on a reductionist and adynamic approach as well as not adequately distinguishing between trait and state. Citation21,Citation22 DSM-III-R was updated to increase the clinical utility of diagnosis based on inputs from practising clinicians and researchers. It also eliminated the diagnostic hierarchy, which, however, resulted in an increasing number of comorbidities being reported. Citation23 DSM-III-R was criticized for being gender-biased, especially for personality disorders. Citation24,Citation25

DSM-IV built on the previous criteria, and added “clinically significant distress or impairment” across diagnostic criteria to improvise on the term “dysfunction” used in its previous version, the concept of which was unclear. Citation26 DSM-IV-TR further detailed the associated features of disorders. Citation27

DSM-5 aimed to bridge these gaps and is currently the most widely used classification system in psychiatry. Citation2,Citation28 With this latest update, the multiaxial system has been discarded, many disorders have been reclassified in a dimensional rather than categorical approach, and increased social sensitivity in terminology (intellectual disability instead of mental retardation) can be observed as striking changes. Citation4,Citation13,Citation29 However, the growing number of disorders outlined in DSM-5 seems to provide little assistance to clinicians in providing optimal treatment. Citation30

The International Classification of Diseases (ICD) was first published in 1893 as the International List of Causes of Death. The purpose was to create a comprehensive statistical manual of diseases, including causes of mortality, and to enhance efforts to improve public health. Citation4 In 1948, when the World Health Organisation (WHO) was entrusted with the update of ICD , psychiatric disorders were first included in its 6th edition. However, the classification system was rejected by most countries. A major update was seen in ICD-8 . Citation32 With the evolutional change of DSM-III , the balance was tipped and ICD-9 aimed to match DSM . Citation13 Since ICD-9 , both DSM and ICD tend to be aligned with some differences. ICD-11 , published in 2019, aimed at improving clinical utility, global application, identify prevalence, and treatment gap to improve public health. Citation3,Citation4

ICD uses short text descriptions of each disorder rather than a list of symptoms. Although used in clinical settings, its main focus is on providing a comprehensive list of all diseases with the aim of public health application. Citation3,Citation33

Surveys on utility of classification systems suggest that, although 57% to 89% of clinicians use classification systems, the most common application is for administrative requirements and assigning a diagnosis for billing and insurance purposes. Communication and teaching were other cited reasons. They found the lowest utility in selection of treatment plans and assessing possible prognosis. Citation30,Citation34,Citation35

Table I. Developments in various versions of the Diagnostic and Statistical Manual of Mental Disorders (DSM).

Cultural perspective


Psychiatry relies considerably on patient self-report and clinician judgement. Citation36 Cultural influences are integral in determining deviations and threshold for illness. For example, in the Japanese culture, Taijin Kyofusho is an acceptable presentation of anxiety, associated with offending others. Citation37,Citation38 Hikikomori is another Japanese presentation associated with social withdrawal for a period of over 6 months. It parallels chronic schizophrenia or apathetic depression, as sometimes there is a strong immersion in personal interests. However, these individuals report no psychological distress and lifelong financial dependency. This condition is acceptable in Japan. Citation39 However, a Japanese immigrant may find it difficult to convey these concerns to a Western clinician who is unaware of this social context. Citation40Citation42

Tseng highlights six different ways in which culture can affect psychiatric syndromes—in the formation of the disorder (pathogenic effect), techniques used to cope with stress (psychoselective effect), modification in clinical presentation (psychoplastic effect), behavioral reactions due to cultural reinforcement (pathoelaborating effect), occurrence (psychofacilitating effect), and perceptions and reactions (psychoreactive effect). Citation43

Although culture-specific syndromes by definition can exist in any society, they are typically identified in Eastern cultures as the classification systems are based in Western societies. They were usually observed during colonization and considered as “peculiar” phenomena that did not fit the classification systems developed by Western nations. Even now, most culture bound syndromes parallel disorders seen in Western-based classification systems, eg, Amok, is closely linked to dissociative disorder, Khyâl cap, or wind attack, is related to panic disorder. Citation44 On the flipside, some disorders such as anorexia nervosa, paranoid schizophrenia, and drug overdose are seen as culture-bound syndromes of the Western cultures. Citation45 Culture-bound syndromes are identified to be emerging from a particular location or cultural group; however, reports of Dhat syndrome, Amok, Koro, Taijin Kyofusho, and Latah have been found in both Western and Eastern countries. Citation44

Current diagnostic criteria are not culture-sensitive, resulting in a 34-fold variation across countries for social anxiety disorder. Citation46 Prevalence rates for major depression varied between 2% and 19% across countries. Citation47 Variance across 10 countries is seen in the illness course, outcome and incidence of schizophrenia. Citation48 Somatization of anxiety and depression is common in Asian patients. Citation49

Medical institutions and training institutes worldwide focus on teaching the dominant classification systems like DSM and ICD , which are influenced by Western illness presentations. Citation50 This may result in ignorance of local cultural presentations, which may be critical for identification and treatment of mental illness in non-Western cultures. Citation51,Citation52

Political perspective


Classification systems are occasionally driven by the prevalent political agendas. In the 19th century, Cartwright diagnosed the defiance and rebellion of African slaves as signs of mental illness and outlined multiple mental disorders he believed Africans were susceptible to. Acts like avoiding work responsibilities or escaping for freedom were considered mental disorders–Dysesthesia Aethiopica and Drapetomania respectively. These so called “diseases” were cured by removing both big toes of the “patients” and thereby making running impossible. Citation53,Citation54

In the late 20 th century, a classic example of classification systems serving political agendas was seen in the Soviet Union. The Moscow School of Psychiatry expanded on the concept of “sluggish schizophrenia” to classify individuals who had symptoms of “reform delusions,” “struggle for the truth,” and “perseverance.” Citation55

Current debates on the political exploitation of psychiatry are contextual to the People’s Republic of China, where the magnitude of abuse seems to be even more widespread than what took place in the Soviet Union. It involves the psychiatric confinement of the Falun Gong movement followers, trade union activists, human rights campaigners, and those objecting to injustice carried out by local authorities. Citation56,Citation57

Legal perspective


Across the world, with a surge in awareness and parental advocacy, there is an increase in provisions made for children with mental illness such as special schools, intervention programs, and concessions in examinations. Citation58,Citation59 A multinational longitudinal study found that over the last 20 years, the prevalence of childhood neuropsychiatric disorders has increased. Further, the age of diagnosis of the disorders was higher than the typical age of onset. Citation60 This may suggest a pattern of misuse by parents and children. Citation61

In recent years, with increasing complexity, public awareness of mental illness as well as laws regarding mental health and disability, there is a surge of psychiatric inputs for resolution of legal conflicts. Citation62

The dependence of psychiatric diagnosis on self-reported symptoms and witness testification heightens its risk of misuse. In 2011, in Norway, a man was sentenced to 21 years in prison for killing 77 people including children and youth in two separate events. Two separate forensic evaluations, 6 months apart, were conducted, with detailed interviews. The first evaluation posited a psychotic disorder and therefore considered him not accountable for the crime; on the other hand, the second evaluation diagnosed him with a narcissistic personality disorder and therefore accountable. Citation63

Premenstrual Dysphoric Disorder (PMDD) has been the centre of controversy, especially in forensic use. In Britain in 1981, several cases of women—one for threatening a police officer and carrying a knife along with 30 other such crimes, and another of a woman who drove into her lover after an argument—were given reduced charge of the quantum of guilt on account of diminished capacity due to severe Premenstrual Syndrome (PMS). Citation64 Many countries, especially in Europe, accept PMS as a legal defence for diminished capacity or insanity. Citation65,Citation66 This may be misused by woman with milder symptoms and astute attorneys. Citation67

The potential for misuse


Lack of affordability results in a significant treatment gap in mental health services. However, with increasing awareness, most government policies have included provisions for mental health services in health insurance coverage. Citation68,Citation69 Classification systems can be misused by insurance companies to deny coverage to those who otherwise may have been eligible.


In DSM-5 , Autistic Disorder, Asperger’s Syndrome, and Pervasive Developmental Disorder—Not Otherwise Specified (PDD-NOS) were discarded and reduced to two diagnoses, Autism Spectrum Disorder and Social Communication Disorder. The autism concept was broadened and replaced by only two categories—social communication impairments and restricted and repetitive behaviors, with more stringent criteria for diagnosis to reduce false positives. It was believed that those individuals previously diagnosed as PDD-NOS as per DSM-IV-TR would either meet ASD or SCD criteria. However, this reclassification has resulted in underidentification of children with significant impairments. Three groups—those with a milder form of the disease, higher cognitive functioning (Asperger’s), and older children are underdiagnosed as a result of the new criteria; and therefore, are denied treatment options. These are also the very same groups for who therapy is found to be most beneficial. Citation70

Trends towards increase in disorder categories, lowered threshold, and symptom severity, all result in an increasing number of children and adults being diagnosed, subsequently seeking treatment, and a rise in the sale of pharmaceutical drugs. This, against the backdrop of simultaneous increase in the percentage of individuals on the DSM task force who have ties with pharmaceutical companies from 57% to 72% between DSM-IV and DSM-5 , challenges the interests underlying the creation of classification systems. Citation71

Misuse of stimulants among college students without diagnosis of ADHD to improve concentration for cognitive and academic enhancement is a growing dilemma, with prevalence rates between 13% and 43%. Furthermore, many of these disorders are ascertained by patient self-report and clinician’s judgment—with increasing access to information on the internet and some training, feigning symptoms may not be as difficult after all. Citation72,Citation73

Until the multiaxial system of classification of psychiatric disorders, Axis II diagnoses were often excluded from insurance coverage, being considered as chronic illness. This denied the much-needed treatment that individuals with personality disorders require to cope with their daily issues. Restrictions on therapy to a fixed number of limited sessions may also make it increasingly difficult for patients to work through all their issues and make a full recovery. Citation74

Individuals at subthreshold levels of depression and anxiety often experience impairment as significant as those who meet criteria. Citation75,Citation76 Hence, in an effort to create stringent criteria and reduce false positives, our classification systems may also be serving the interests of insurance companies by excluding individuals from coverage, and denying therapy and treatment to individuals who might benefit from them.


Issues with the current classification systems


Reliability and validity


An overarching problem with many psychiatric disorders is that validity and reliability research originally carried out for a few groups of disorders in DSM has not been carried out for most of the remaining diagnoses in the manual. Citation31 Even for DSM-5 , field trials yielded low reliability, with nonexpert clinicians diagnosing patient groups based on checklists rather than standard diagnostic interviews. Citation77Citation79

Multiaxial system


Introduced in DSM-III , the multiaxial system was created to help clinicians ensure a holistic diagnosis. However, concerns regarding overlap in symptoms between Axis I and II disorders were raised. Citation80 Significant comorbidities have been observed between social anxiety disorder and avoidant personality disorder (PD), Citation81 schizophrenia and schizotypal PD, Citation82 and substance-use disorders and antisocial PD. Citation83 Segregation of medical illnesses on Axis III implied that mental disorders did not have a medical status. Citation84 DSM-5 discarded the multiaxial system in an effort to do away with the above limitations. Citation2 It extensively expanded on possible stressors under Z codes; however without the multiaxial system, they may be dismissed or ignored. Citation85

Comorbidity


Comorbidities increased dramatically when the exclusion system was eliminated from DSM-III-TR and disorders were divided into discrete categories. Citation23 Presence of any DSM-III-TR disorder increased the odds of having almost any other disorder. Citation86 Comorbidity affects the specificity with which diagnosis directs treatment. It is also associated with more severe outcomes, impairment, poorer quality of life, higher chronicity rates, resistance to treatment, and a greater suicide risk than any condition alone. Citation87Citation89 Epidemiological studies revealed high rates of comorbidity —not only within diagnostic groups but also between disorders. Citation90Citation92

Furthermore, current psychopharmacological treatments are effective for multiple disorders. Selective serotonin reuptake inhibitors are effective in the treatment of depression, eating disorders, and anxiety disorders. Citation93 Likewise, second-generation antipsychotic medications are effective alone or as adjunctive treatments for nonpsychotic mood disorders. Citation94 Psychotherapy has also been successfully generalized to treat multiple disorders. Citation95

Thus, high rates of comorbidity, and nonspecificity of both pharmacological and psychosocial treatments question the specificity of the disorders and their purported underlying mechanisms. Citation4

Categorization or dimensional approach?


Several attempts have been made at classifying psychiatric disorders based on various criteria, including etiology, phenomenology, onset age, longitudinal course, and prognosis. Citation4,Citation96Citation98 However, these categories are not mutually exclusive and the overlap of symptoms and presentations are common. Currently, DSM adopts both categorical as well as dimensional approaches in classifying disorders. Schizophrenia and autism are two examples of a dimensional approach, and perhaps future shifts in this direction are likely. Citation2,Citation99

Heterogeneity within diagnoses


Heterogeneity is seen across persons and across symptoms. Within individuals, for instance, Borderline Personality Disorder (BPD) consists of nine diagnostic criteria of which a minimum of five need to be present for the diagnosis. This results in a staggering 256 distinct presentations of BPD. Citation100 Strikingly, this number is relatively small when compared with other conditions—there are 636 120 ways to have post-traumatic stress disorder. Citation101

Future directions


Alternative methods of diagnosis


Diagnosis in psychiatry relies heavily on clinical interview and clinician judgment. Psychometric tests are used to aid the diagnosis; however there are no internationally standardized tests that are reliable and valid in measuring disorders. Citation102 With advances in artificial intelligence, imaging, and genetic testing, there may be a way forward towards alternative methods of diagnosis which in turn would result in alternative classification systems. Citation103Citation105

Artificial intelligence has aided the classification of diseases using techniques such as expert systems, artificial neural networks, linear programming, database systems, evolutionary algorithms, and swarm intelligence. Citation106,Citation107 Within psychiatry, machine learning has shown promising results in stratification based on symptom type, Citation108 symptom severity as well as behavior within a single diagnosis, Citation109 in predicting those at risk, Citation110 course and prognosis of illnesses, Citation111 in its ability to differentiate between diagnostic categories, Citation112 understanding correlations between structural and functional alterations through its application in neuroimaging data, Citation113 as well as in transdiagnostic studies clustering symptoms across diagnosis. Citation114

Meta-analysis indicates that structural imaging has 80% sensitivity and specificity in distinguishing between schizophrenic subjects and normal adults. Citation115 Similar results have been found for Major Depressive Disorder. Citation116 Functional magnetic resonance imaging (fMRI) studies have not only be able to accurately distinguish schizophrenia, bipolar disorder, and unipolar disorder, but have also shown evidence for overlapping anatomical changes in schizophrenia and bipolar disorder. Citation117,Citation118

Alternative methods of classification


Current dissatisfaction with the categorical classification systems have emerged predominantly from lack of support for the current nosology in biomarker research. In this chaos, Research Domain Criteria (RDoC) has been seen as a frontrunner for an alternative method of classification. Citation119 Established in 2009, the goal of this research initiative is precision medicine for psychiatric disorders—to facilitate the modification of current diagnosis, improvement of treatment and prevention of mental illness. Its dimensional approach views basic behavior, cognitive domains, and brain circuits on a continuum of functionality from normal to abnormal. It integrates neurobiological data, observable behaviors, and self-reports. Citation120,Citation121

The Hierarchical Taxonomy of Psychopathology (HiTOP) is an alternative classification system suggested by Kotov and colleagues. Citation122 Based on a four-level hierarchical structure, it is composed of broad spectra of internalizing pathology, externalizing pathology, thought disorder, and detachment at the top of the hierarchy. These are divided into factors which are further divided into syndromes or traits. Signs and symptoms form the base of the structure. Using multivariate factor analysis, the goal is to create an empirically based dimensional classification system. It reduces heterogeneity by grouping related symptoms, reduces comorbidity by combining syndromes into spectra, and it has a dimensional approach which eliminates issues regarding categorization. Citation123

Conclusion


While classification systems are essential and do indeed serve important functions in the practice of psychiatry, their inherent limitations result in errors on both sides of the diagnostic spectrum, from overdiagnosis to underdiagnosis. It is important to recognize the fissures in the framework of our contemporary classification systems. Beyond our theoretical constructs, the patient in front of us expects effective treatment. Our goal should be to go beyond the limitations of our classification systems to fulfil the expectations of our patients, as well as those of ourselves as humane and effective psychiatrists.


The authors declare no conflict of interest

REFERENCES

  • LempérièreTThe importance of classifications in psychiatryEncephale19952137
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders2013 5th ed. Arlington, VA American Psychiatric Publishing
  • World Health OrganizationInternational Classification of Diseases2019World Health Organization
  • ClarkLACuthbertBLewis-FernándezRNarrowWEReedGMThree approaches to understanding and classifying mental disorder: ICD-11, DSM-5, and the National Institute of Mental Health’s Research Domain Criteria (RDoC)Psychol Sci Public Interes201718272145
  • ShorterEThe history of nosology and the rise of the diagnostic and statistical manual of mental disordersDialogues Clin Neurosci2015171596725987864
  • KendlerKSFirstMBAlternative futures for the DSM revision process: Iteration v. paradigm shiftBr J Psychiatry2010197426326520884947
  • BhugraDPsychiatry in ancient Indian texts: A reviewHist Psychiatry199231016718611623029
  • CheCTGeorgeVIjinuTPPushpangadanPAndrae-MarobelaKTraditional medicine Pharmacognosy: Fundamentals, Applications and Strategy2016 London, UK Elsevier Inc 1530
  • van BergenLEmil Kraepelin: grandfather of the DSMMed Confl Surviv2015313-415816126708489
  • SeitelbergerFTheodor Meynert (1833-1892), pioneer and visionary of brain researchJ Hist Neurosci19976326427411619863
  • HoutsACFifty years of psychiatric nomenclature: Reflections on the 1943 war Department Technical Bulletin, Medical 203J Clin Psychol200056793596710902952
  • FischerBAA review of American psychiatry through its diagnoses: the history and development of the Diagnostic and Statistical Manual of Mental DisordersJ Nerv Ment Dis2012200121022103023197117
  • BlashfieldRKKeeleyJWFlanaganEHMilesSRThe cycle of classification: DSM-I through DSM-5Annu Rev Clin Psychol2014101255124679178
  • Hale Jr.NGThe Rise and Crisis of Psychoanalysis in the United States: Freud and the Americans, 1917–19851995 New York, NY Oxford University Press
  • MayesRHorwitzA VDSM-III and the revolution in the classification of mental illnessJ Hist Behav Sci20054124926715981242
  • GurlandBJFleissJLSharpeLet alCross-national study of diagnosis of mental disorders: hospital diagnoses and hospital patients in New York and LondonCompr Psychiatry197011118255411210
  • KendellRECooperJEGourlayJRMAJJRMCopelandJRMSharpeLGurlandBJDiagnostic criteria of american and british psychiatristsArch Gen Psychiatry19712521231305569450
  • FeighnerJPRobinsEGuzeSBWoodruffRAWinokurGMunozRDiagnostic criteria for use in psychiatric researchArch Gen Psychiatry197226157635009428
  • KendlerKSMuñozRAMurphyGThe development of the feighner criteria: A historical perspectiveAm J Psychiatry2010167213414220008944
  • American Psychiatric AssociationDiagnostic and Statistical Manual of Mental Disorders19803rd ed.Washington, DCAmerican Psychiatric Association
  • VaillantGEThe disadvantages of DSM-III outweigh its advantagesAm J Psychiatry19841414542545
  • FaustDMinerRAThe empiricist and his new clothes: DSM-III in perspectiveAm J Psychiatry198614389629673728742
  • KesslerRCMcGonagleKAZhaoet alLifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the united states: results from the national comorbidity surveyArch Gen Psychiatry19945118198279933
  • HamiltonSRothbartMDawesRMSex bias, diagnosis, and DSM-IIISex Roles1986155-6269274
  • FordMRWidigerTASex bias in the diagnosis of histrionic and antisocial personality disordersJ Consult Clin Psychol19895723013052708619
  • WakefieldJCDisorder as harmful dysfunction: a conceptual critique of DSM-III-R’s definition of mental disorderPsychol Rev19929922322471594724
  • SurísAHollidayRNorthCSThe evolution of the classification of psychiatric disordersBehav Sci (Basel, Switzerland)201661
  • López-MuñozFGarcía-GarcíaPSáiz-RuizJet alA bibliometric study of the use of the classification and diagnostic systems in psychiatry over the last 25 yearsPsychopathology200841421422518408417
  • SchalockRLLuckassonRAShogrenKAet alThe renaming of mental retardation: Understanding the change to the term intellectual disabilityIntellect Dev Disabil200745211612417428134
  • ReedGMMendonça CorreiaJEsparzaPSaxenaSMajMThe WPA-WHO global survey of psychiatrists’ attitudes towards mental disorders classificationWorld Psychiatry201110211813121633689
  • ChmielewskiMClarkLABagbyRMWatsonDMethod matters: Understanding diagnostic reliability in DSM-IV and DSM-5J Abnorm Psychol2015124376476926098046
  • World Health OrganizationInternational Statistical Classification of Diseases, Injuries, and Causes of Death1967Geneva, SwitzerlandWorld Health Organization
  • KeeleyJWReedGMRobertsMCet alDeveloping a science of clinical utility in diagnostic classification systems field study strategies for ICD-11 mental and behavioral disordersAm Psychol201671131626766762
  • FirstMBBhatVAdlerDet alHow do clinicians actually use the Diagnostic and Statistical Manual of Mental Disorders in clinical practice and why we need to know moreJ Nerv Ment Dis20142021284184425390931
  • FirstMBRebelloTJKeeleyJWet alDo mental health professionals use diagnostic classifications the way we think they do? A global surveyWorld Psychiatry201817218719529856559
  • BhugraDEasterAMallarisYGuptaSClinical decision making in psychiatry by psychiatristsActa Psychiatr Scand2011124540341121740401
  • KirmayerLJThe place of culture in psychiatric nosology: Taijin kyofusho and DSM-III-RJ Nerv Ment Dis19911791191985144
  • SomeyaTTakahashiMTakahashiMIs DSM widely accepted by Japanese clinicians?Psychiatry Clin Neurosci200155543745011555338
  • TeoARGawACHikikomori, a Japanese culture-bound syndrome of social withdrawal?: A proposal for DSM-5J Nerv Ment Dis2010198644444920531124
  • Lewis-FernándezRKrishan AggarwalNAggarwalNKCulture and psychiatric diagnosisAdv Psychosom Med201333153023816860
  • KohrtBARasmussenAKaiserBNet alCultural concepts of distress and psychiatric disorders: literature review and research recommendations for global mental health epidemiologyInt J Epidemiol201443236540624366490
  • Tanaka-MatsumiJTaijin Kyofusho: diagnostic and cultural issues in Japanese psychiatryCult Med Psychiatry197933231245520018
  • TsengW-SHandbook of Cultural Psychiatry2001 San Diego, CA Academic Press
  • TsengWSFrom peculiar psychiatric disorders through culture-bound syndromes to culture-related specific syndromesTranscult Psychiatry200643455457617166946
  • BaigBJSocial and transcultural aspects of psychiatry Companion to Psychiatric Studies2010 Elsevier 109119
  • KesslerRCThe World Health Organization International Consortium in Psychiatric Epidemiology (ICPE): initial work and future directions - the NAPE Lecture 1998Acta Psychiatr Scand19999912910066001
  • KesslerRCBrometEJThe epidemiology of depression across culturesAnnu Rev Public Health201334111913823514317
  • JablenskyASartoriusNErnbergGet alSchizophrenia: manifestations, incidence and course in different cultures A World Health Organization Ten-Country StudyPsychol Med Monogr Suppl1992201971565705
  • KhambatyMParikhRMCultural aspects of anxiety disorders in IndiaDialogues Clin Neurosci201719211712628867936
  • FernandoSGlobalization of psychiatry - a barrier to mental health developmentInt Rev Psychiatry201426555155725343630
  • U.S. Department of Health and Human ServicesCulture Counts: The Influence of Culture and Society on Mental Health2001U.S. Department of Health and Human Services
  • VentriglioAAyonrindeOBhugraDRelevance of culture-bound syndromes in the 21st centuryPsychiatry Clin Neurosci20167013626332813
  • CartwrightSReport on the diseases and physical peculiarities of the Negro raceNew-Orleans Med Surg J18517691715
  • Myers IIBE“Drapetomania”: Rebellion, Defiance and Free Black Insanity in the Antebellum United States2014 Los Angeles, CA University of California
  • Van VorenRPolitical abuse of psychiatry - An historical overviewSchizophr Bull2010361333519892821
  • MunroRChina’s Psychiatric Inquisition: Dissent, Psychiatry and the Law in Post-1949 China2006 London, UK Wildy, Simmonds & Hill
  • MunroRJudicial psychiatry in China and its political abusesColumbia J Asian Law2000141128
  • KarandeSSholapurwalaRKulkarniMManaging specific learning disability in schools in IndiaIndian Pediatr201148751552021813921
  • KoegelLMatos-FredenRLangRKoegel RInterventions for children with autism spectrum disorders in inclusive school settingsCogn Behav Pract2012193401412
  • AtladottirHOGyllenbergDLangridgeAet alThe increasing prevalence of reported diagnoses of childhood psychiatric disorders: a descriptive multinational comparisonEur Child Adolesc Psychiatry201524217318324796725
  • MehtaMUse and abuse of specific learning disability certificatesInd Psychiatry J20112027723271859
  • HalleckSLHogeSKMillerRDSadoffRLHalleckNHThe use of psychiatric diagnoses in the legal process: Task force report of the American Psychiatric AssociationBull Am Acad Psychiatry Law19922044815001482801
  • MelleIThe Breivik case and what psychiatrists can learn from itWorld Psychiatry2013121162123471788
  • British Legal Debate: Premenstrual Tension and Criminal BehaviourThe New York Times Published December 29, 1981
  • PressMPPremenstrual Stress Syndrome as a Defense in Criminal CasesDuke Law J198319831176
  • DaltonKCyclical criminal acts in premenstrual syndromeLancet1980316820310701071
  • SolomonLPremenstrual syndrome: the debate surrounding criminal defenseMaryl Law Rev199554571
  • RowanKMcAlpineDDBlewettLAAccess and cost barriers to mental health care, by insurance status, 1999–2010Health Aff2013321017231730
  • BijalASKumarCNManjunathaNGowdaMBasavarajuVMathSBHealth insurance and mental illnessIndian J Psychiatry201961Suppl 4S791S79731040476
  • MasiADeMayoMMGlozierNGuastellaAJAn overview of autism spectrum disorder, heterogeneity and treatment optionsNeurosci Bull201733218319328213805
  • CosgroveLKrimskySA comparison of DSM-IV and DSM-5 panel members’ financial associations with industry: a pernicious problem persistsPLoS Med201293e100119022427747
  • WeyandtLLOsterDRMarracciniMEet alPrescription stimulant medication misuse: Where are we and where do we go from here?Exp Clin Psychopharmacol201624540041427690507
  • BensonKFloryKHumphreysKLLeeSSMisuse of stimulant medication among college students: a comprehensive review and meta-analysisClin Child Fam Psychol Rev2015181507625575768
  • KerstingKAxis II - gets short shriftsMonit Psychol200435350
  • HallerHCramerHLaucheRGassFDobosGJThe prevalence and burden of subthreshold generalized anxiety disorder: a systematic reviewBMC Psychiatry201414112824886240
  • CuijpersPSmitFOostenbrinkJDe GraafRTen HaveMBeekmanAEconomic costs of minor depression: a population-based studyActa Psychiatr Scand2007115322923617302623
  • RegierDANarrowWEClarkeDEet alDSM-5 field trials in the United States and Canada, part II: Test-retest reliability of selected categorical diagnosesAm J Psychiatry20131701597023111466
  • NarrowWEClarkeDEKuramotoJet alDSM-5 field trials in the United States and Canada, part III: Development and reliability testing of a cross-cutting symptom assessment for DSM-5Am J Psychiatry20131701718223111499
  • JonesKDA critique of the DSM-5 field trialsJ Nerv Ment Dis2012200651751922652616
  • RøysambEKendlerKSTambsKet alThe joint structure of DSM-IV Axis I and Axis II disordersJ Abnorm Psychol2011120119820921319931
  • CoxBJPaguraJSteinMBSareenJThe relationship between generalized social phobia and avoidant personality disorder in a national mental health surveyDepress Anxiety200926435436219031488
  • PicchioniMMWalsheMToulopoulouTet alGenetic modelling of childhood social development and personality in twins and siblings with schizophreniaPsychol Med20104081305131619863839
  • RuizMAPincusALSchinkaJAExternalizing pathology and the five-factor model: a meta-analysis of personality traits associated with antisocial personality disorder, substance use disorder, and their co-occurrenceJ Pers Disord200822436538818684050
  • BattleDEDiagnostic and Statistical Manual of Mental Disorders (DSM)CoDAS201325219119224413388
  • KressVEMintonCABAdamsonNAPayloMJPopeVThe removal of the multiaxial system in the DSM-5: implications and practice suggestions for counselorsProf Couns201443191201
  • BoydJHBurkeJDGruenbergEet alExclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromesArch Gen Psychiatry198441109839896477056
  • MöllerHJBandelowBVolzHPBarnikolUBSeifritzEKasperSThe relevance of ‘mixed anxiety and depression’ as a diagnostic category in clinical practiceEur Arch Psychiatry Clin Neurosci2016266872573627002521
  • González-RoblesADíaz-GarcíaAMiguelCGarcía-PalaciosABotellaCComorbidity and diagnosis distribution in transdiagnostic treatments for emotional disorders: A systematic review of randomized controlled trialsPLoS One20181311
  • Hofmeijer-SevinkMKBatelaanNMvan MegenHJGMet alClinical relevance of comorbidity in anxiety disorders: a report from the Netherlands Study of Depression and Anxiety (NESDA)J Affect Disord20121371-310611222240085
  • GadermannAMAlonsoJVilagutAMZaslavskyAMKesslerRCG Comorbidity and disease burden in the national comorbidity survey replication (NCS-R)Depress Anxiety201229979780622585578
  • KesslerRCAvenevoliSMcLaughlinKAet alLifetime co-morbidity of DSM-IV disorders in the US National Comorbidity Survey Replication Adolescent Supplement (NCS-A)Psychol Med20124291997201022273480
  • KesslerRCChiuWTDemlerOMerikangasKRWaltersEEPrevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey ReplicationArch Gen Psychiatry200562661762715939839
  • VaswaniMLindaFKRameshSRole of selective serotonin reuptake inhibitors in psychiatric disorders: A comprehensive reviewProg Neuro-Psychopharmacology Biol Psychiatry200327185102
  • RobertsRJLohanoKKEl-MallakhRSAntipsychotics as antidepressantsAsia-Pacific Psychiatry20168317918825963405
  • HofmannSGAsnaaniAVonkIJJSawyerATFangAThe efficacy of cognitive behavioral therapy: a review of meta-analysesCognit Ther Res2012365427440
  • PienkosEGierschAHansenMet alHallucinations beyond voices: a conceptual review of the phenomenology of altered perception in psychosisSchizophr Bull201945S67S7730715544
  • CarragherNKruegerRFEatonNRet alDisorders without borders: current and future directions in the meta-structure of mental disordersSoc Psychiatry Psychiatr Epidemiol201550333935025557024
  • BenazziFClassifying mood disorders by age-at-onset instead of polarityProg Neuropsychopharmacol Biol Psychiatry2009331869318992784
  • KupferDJRegierDANeuroscience, clinical evidence, and the future of psychiatric classification in DSM-5Am J Psychiatry2011168767267421724672
  • AndiónÓFerrerMCalvoNet alExploring the clinical validity of borderline personality disorder componentsCompr Psychiatry2013541344022794943
  • Galatzer-LevyIRBryantRA636,120 ways to have posttraumatic stress disorderPerspect Psychol Sci20138665166226173229
  • van Heugten-van der KloetDvan HeugtenTThe classification of psychiatric disorders according to DSM-5 deserves an internationally standardized psychological test battery on symptom levelFront Psychol20156110826300808
  • HoeheMRMorris-RosendahlDJThe role of genetics and genomics in clinical psychiatryDialogues Clin Neurosci201820316917730581286
  • PohlKMSabuncuMRA unified framework for MR based disease classification Lecture Notes in Computer Science (Including Subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)2009300313
  • FalkaiPSchmittAAndreasenNForty years of structural brain imaging in mental disorders: Is it clinically useful or not?Dialogues Clin Neurosci201820317918630581287
  • ErguzelTOzekesSArtificial intelligence approaches in psychiatric disordersJ Neurobehav Sci20141252
  • JiangFJiangYZhiHet al Artificial intelligence in healthcare: Past, present and futureStroke Vasc Neurol20172423024329507784
  • ZhangTKoutsoulerisNMeisenzahlEDavatzikosCHeterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysisSchizophr Bull2015411748425261565
  • BorgwardtSKoutsoulerisNAstonJet alDistinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognitionSchizophr Bull20133951105111422969150
  • KoutsoulerisNDavatzikosCBottlenderRet alEarly recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classificationSchizophr Bull20123861200121521576280
  • RhebergenDLamersFSpijkerJde GraafRBeekmanATFPenninxBWJHCourse trajectories of unipolar depressive disorders identified by latent class growth analysisPsychol Med20124271383139622053816
  • SchnackHGNieuwenhuisMvan HarenNEMet alCan structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjectsNeuroimage20148429930624004694
  • OrrùGPettersson-YeoWMarquandAFSartoriGMechelliAUsing Support Vector Machine to identify imaging biomarkers of neurological and psychiatric disease: A critical reviewNeurosci Biobehav Rev20123641140115222305994
  • GrisanzioKAGoldstein-PiekarskiANWangMYRashed AhmedAPSamaraZWilliamsLMTransdiagnostic symptom clusters and associations with brain, behavior, and daily function in mood, anxiety, and trauma disordersJAMA Psychiatry201875220120929197929
  • KambeitzJKambeitz-IlankovicLLeuchtSet alDetecting neuroimaging biomarkers for schizophrenia: A meta-analysis of multivariate pattern recognition studiesNeuropsychopharmacology20154071742175125601228
  • KambeitzJCabralCSacchetMDet alDetecting neuroimaging biomarkers for depression: a meta-analysis of multivariate pattern recognition studiesBiol Psychiatry201782533033828110823
  • Librenza-GarciaDKotzianBJYangJet alThe impact of machine learning techniques in the study of bipolar disorder: A systematic reviewNeurosci Biobehav Rev20178053855428728937
  • BirurBKraguljacNVSheltonRCLahtiACBrain structure, function, and neurochemistry in schizophrenia and bipolar disorder—a systematic review of the magnetic resonance neuroimaging literatureNPJ Schizophr2017311528560261
  • CuthbertBNThe RDoC framework: Facilitating transition from ICD/DSM to dimensional approaches that integrate neuroscience and psychopathologyWorld Psychiatry2014131283524497240
  • CuthbertBNInselTRToward the future of psychiatric diagnosis: the seven pillars of RDoCBMC Med201311112623672542
  • MorrisSECuthbertBNResearch Domain Criteria: cognitive systems, neural circuits, and dimensions of behaviorDialogues Clin Neurosci2012141293722577302
  • KotovRKruegerRFWatsonDet alThe Hierarchical Taxonomy of Psychopathology (HiTOP): A dimensional alternative to traditional nosologiesJ Abnorm Psychol2017126445447728333488
  • KruegerRFKotovRWatsonDet alProgress in achieving quantitative classification of psychopathologyWorld Psychiatry201817328229330229571